Cargando…

Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time

BACKGROUND: Former critically ill children show an epigenetic age deceleration 2 years after paediatric intensive care unit (PICU) admission as compared with normally developing healthy children, with stunted growth in height 2 years further in time as physical correlate. This was particularly prono...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhorebeek, Ilse, Coppens, Grégoire, Güiza, Fabian, Derese, Inge, Wouters, Pieter J., Joosten, Koen F., Verbruggen, Sascha C., Van den Berghe, Greet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354984/
https://www.ncbi.nlm.nih.gov/pubmed/37468957
http://dx.doi.org/10.1186/s13148-023-01530-9
_version_ 1785075042039627776
author Vanhorebeek, Ilse
Coppens, Grégoire
Güiza, Fabian
Derese, Inge
Wouters, Pieter J.
Joosten, Koen F.
Verbruggen, Sascha C.
Van den Berghe, Greet
author_facet Vanhorebeek, Ilse
Coppens, Grégoire
Güiza, Fabian
Derese, Inge
Wouters, Pieter J.
Joosten, Koen F.
Verbruggen, Sascha C.
Van den Berghe, Greet
author_sort Vanhorebeek, Ilse
collection PubMed
description BACKGROUND: Former critically ill children show an epigenetic age deceleration 2 years after paediatric intensive care unit (PICU) admission as compared with normally developing healthy children, with stunted growth in height 2 years further in time as physical correlate. This was particularly pronounced in children who were 6 years or older at the time of critical illness. As this age roughly corresponds to the onset of adrenarche and further pubertal development, a relation with altered activation of endocrine pathways is plausible. We hypothesised that children who have been admitted to the PICU, sex- and age-dependently show long-term abnormal DNA methylation within genes involved in steroid hormone synthesis or steroid sulphation/desulphation, possibly aggravated by in-PICU glucocorticoid treatment, which may contribute to stunted growth in height further in time after critical illness. RESULTS: In this preplanned secondary analysis of the multicentre PEPaNIC-RCT and its follow-up, we compared the methylation status of genes involved in the biosynthesis of steroid hormones (aldosterone, cortisol and sex hormones) and steroid sulphation/desulphation in buccal mucosa DNA (Infinium HumanMethylation EPIC BeadChip) from former PICU patients at 2-year follow-up (n = 818) and healthy children with comparable sex and age (n = 392). Adjusting for technical variation and baseline risk factors and corrected for multiple testing (false discovery rate < 0.05), former PICU patients showed abnormal DNA methylation of 23 CpG sites (within CYP11A1, POR, CYB5A, HSD17B1, HSD17B2, HSD17B3, HSD17B6, HSD17B10, HSD17B12, CYP19A1, CYP21A2, and CYP11B2) and 4 DNA regions (within HSD17B2, HSD17B8, and HSD17B10) that were mostly hypomethylated. These abnormalities were partially sex- (1 CpG site) or age-dependent (7 CpG sites) and affected by glucocorticoid treatment (3 CpG sites). Finally, multivariable linear models identified robust associations of abnormal methylation of steroidogenic genes with shorter height further in time, at 4-year follow-up. CONCLUSIONS: Children who have been critically ill show abnormal methylation within steroidogenic genes 2 years after PICU admission, which explained part of the stunted growth in height at 4-year follow-up. The abnormalities in DNA methylation may point to a long-term disturbance in the balance between active sex steroids and mineralocorticoids/glucocorticoids after paediatric critical illness, which requires further investigation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-023-01530-9.
format Online
Article
Text
id pubmed-10354984
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103549842023-07-20 Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time Vanhorebeek, Ilse Coppens, Grégoire Güiza, Fabian Derese, Inge Wouters, Pieter J. Joosten, Koen F. Verbruggen, Sascha C. Van den Berghe, Greet Clin Epigenetics Research BACKGROUND: Former critically ill children show an epigenetic age deceleration 2 years after paediatric intensive care unit (PICU) admission as compared with normally developing healthy children, with stunted growth in height 2 years further in time as physical correlate. This was particularly pronounced in children who were 6 years or older at the time of critical illness. As this age roughly corresponds to the onset of adrenarche and further pubertal development, a relation with altered activation of endocrine pathways is plausible. We hypothesised that children who have been admitted to the PICU, sex- and age-dependently show long-term abnormal DNA methylation within genes involved in steroid hormone synthesis or steroid sulphation/desulphation, possibly aggravated by in-PICU glucocorticoid treatment, which may contribute to stunted growth in height further in time after critical illness. RESULTS: In this preplanned secondary analysis of the multicentre PEPaNIC-RCT and its follow-up, we compared the methylation status of genes involved in the biosynthesis of steroid hormones (aldosterone, cortisol and sex hormones) and steroid sulphation/desulphation in buccal mucosa DNA (Infinium HumanMethylation EPIC BeadChip) from former PICU patients at 2-year follow-up (n = 818) and healthy children with comparable sex and age (n = 392). Adjusting for technical variation and baseline risk factors and corrected for multiple testing (false discovery rate < 0.05), former PICU patients showed abnormal DNA methylation of 23 CpG sites (within CYP11A1, POR, CYB5A, HSD17B1, HSD17B2, HSD17B3, HSD17B6, HSD17B10, HSD17B12, CYP19A1, CYP21A2, and CYP11B2) and 4 DNA regions (within HSD17B2, HSD17B8, and HSD17B10) that were mostly hypomethylated. These abnormalities were partially sex- (1 CpG site) or age-dependent (7 CpG sites) and affected by glucocorticoid treatment (3 CpG sites). Finally, multivariable linear models identified robust associations of abnormal methylation of steroidogenic genes with shorter height further in time, at 4-year follow-up. CONCLUSIONS: Children who have been critically ill show abnormal methylation within steroidogenic genes 2 years after PICU admission, which explained part of the stunted growth in height at 4-year follow-up. The abnormalities in DNA methylation may point to a long-term disturbance in the balance between active sex steroids and mineralocorticoids/glucocorticoids after paediatric critical illness, which requires further investigation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-023-01530-9. BioMed Central 2023-07-19 /pmc/articles/PMC10354984/ /pubmed/37468957 http://dx.doi.org/10.1186/s13148-023-01530-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vanhorebeek, Ilse
Coppens, Grégoire
Güiza, Fabian
Derese, Inge
Wouters, Pieter J.
Joosten, Koen F.
Verbruggen, Sascha C.
Van den Berghe, Greet
Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
title Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
title_full Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
title_fullStr Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
title_full_unstemmed Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
title_short Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
title_sort abnormal dna methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354984/
https://www.ncbi.nlm.nih.gov/pubmed/37468957
http://dx.doi.org/10.1186/s13148-023-01530-9
work_keys_str_mv AT vanhorebeekilse abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT coppensgregoire abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT guizafabian abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT dereseinge abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT wouterspieterj abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT joostenkoenf abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT verbruggensaschac abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime
AT vandenberghegreet abnormaldnamethylationwithingenesofthesteroidogenesispathwaytwoyearsafterpaediatriccriticalillnessandassociationwithstuntedgrowthinheightfurtherintime